Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Correction: Hansa Biopharma: increase in number of shares and votes

The correction only concerns the removal of the reference to the EU Market Abuse Regulation that was incorrectly included in the original press release, distributed at 8:00am CEST on May 03, 2024, and inclusion of reference to the Swedish Financial Instruments Trading Act (1991:980). Lund, Sweden May 3, 2024. Hansa Biopharma AB (publ), (“Hansa” or the “Company”) (Nasdaq Stockholm: HNSA) today announced that the company’s registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby the number of votes

Form 8.3 - BHP Group Limited

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +-----------------------------------------------------+------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+-----------------------------------------------------+------------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from

Form 8.3 - Anglo American Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +-----------------------------------------------------+-----------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+-----------------------------------------------------+-----------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from 1(a):

#24-43 Garpco Aktiebolag approved for listing at NGM

Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in Garpco Aktiebolag at NGM. The first day of trading has been set to May 7, 2024.   Information regarding the affected instruments:   Listing name: Garpco B Exchange symbol: GARPCO B ISIN-code: SE0001823352 CFI-code: ESVUFR FISN-code: GARPCO/SH B Instrument-ID: EMUK Tick size table/liquidity band: 2 Number of issued shares: 861 833 First day of trading: 2024-05-07 Market-ID: NSME Segment-ID: NSSE   For more information about this Market Notice, please

Changes in Nordea’s own shares

Nordea Bank AbpStock exchange release – Changes in company’s own shares3 May 2024 at 12.00 EET A total of 915 own shares held by the company were today transferred without consideration to participants of Nordea Bank Abp’s variable remuneration programmes. Based on the resolution of the Board of Directors announced on 21 March 2024, Nordea has transferred 915 own shares held by the company to settle its commitments to participants of its variable remuneration programmes. Following the transfer of own shares, Nordea holds 3,513,966 treasury shares for remuneration purposes.

Compliance with Market Abuse Regulations

3 May 2024   Fidelity China Special Situations PLC (“the Company”)   LEI: 54930076MSJ0ZW67JB75   Compliance with Market Abuse Regulations   The Company wishes to notify the market that the closed period of the Company in relation to its annual results for the year ended 31 March 2024 will commence on 3 May 2023 (today) and is anticipated to end no sooner than 10 June 2024.   The Company confirms that all inside information (as defined in the EU Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory

Management change in Bravida Division South

Bravida’s internal investigation into why Region Skåne terminated its framework agreement with Bravida Sverige AB shows two things: that intentional overbilling has occurred, and that there have been major deficiencies in the handling of the matter and in the customer relationship with Region Skåne. As a result, the head of Division South will have to leave Bravida.On April 4, 2024, Bravida initiated an internal investigation following Region Skåne's decision to terminate its framework agreement with Bravida Sverige AB.The investigation, presented on April 29, 2024, revealed that two

Mydecine applies for management cease trade order

MYDECINE APPLIES FOR MANAGEMENT CEASE TRADE ORDER VANCOUVER, British Columbia, 3 May 2024 — Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that it has requested a temporary Management Cease Trade Order (“MCTO”) from the British Columbia Securities Commission (“BCSC”) in connection with the Company’s filing of its audited annual financial statements (the “Audited Financial Statements”) and MD&A for the financial year ended December 31, 2023. The Company is requesting the MCTO in order to secure additional time to finalize its

#24-42 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Nowonomics AB

The unit issue in Nowonomics AB (“The Company”) is now registered with the Swedish Companies Registration Office and the last day of trading in paid subscribed units has been set for May 6, 2024. The first day of trading for the Company’s warrants series 6 (TO6) has been set for May 15, 2024.Information regarding the affected instruments:Listing name: Nowonomics BTUExchange symbol: NOWO BTUISIN-code: SE0021770856CFI-code: MCMUXRFISN-code: NOWONOMICS/UT 5 AK + 3 TOLast day of trading: 2024-05-06Instrument-ID: ECMDMarket-ID: NSMESegment-ID: NSSE Listing name:

Notice to attend the Annual General Meeting in ExpreS2ion Biotech Holding AB (publ)

N.B. This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies between the versions, the Swedish version shall prevail. The shareholders of ExpreS2ion Biotech Holding AB (publ), reg. no. 559033-3729 (the "Company"), are hereby given notice to attend the Annual General Meeting to be held on 5 June 2024 at 10.30 (CEST) on Mindpark, Bredgatan 11, Helsingborg, Sweden. The entrance to the meeting and registration will commence at 10.00 (CEST). The Board of Directors have decided, pursuant to the Company’s articles of association, that

Invitation to presentation of SBB’s interim report January-March 2024

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) will publish interim report January-March 2024 on 6 May 2024 at 08:00 CEST. SBB’s CEO Leiv Synnes will present the results on the same day at 10:00 CEST via conference call and webcast. The presentation will be held in English and will be concluded with a Q&A session. Questions can be asked on the conference call or in written form through the webcast. The report will be available at: https://corporate.sbbnorden.se/en/reports-and-presentations/ If you wish to participate via webcast, please use the link below. Via the webcast you

Dolphin Drilling AS: Mandatory notification of trade

Oslo, 3 May 2024: Reference is made to the stock exchange announcement published by Dolphin Drilling AS ("Dolphin Drilling" or the "Company") on 10 April 2024 regarding the successful private placement of 72,000,000 new shares in the Company (the "Private Placement") in two tranches. As described in said notice, and pursuant to a share lending agreement dated 10 April 2024, S.D. Standard ETC Plc ("SDS"), a company closely associated with Martin Nes, chair of the board of directors and primary insider of the Company, will lend shares for settlement vis-à-vis applicants in tranche 2 of the

Sandvik completes the acquisition of Almü

Sandvik has completed the previously announced acquisition of Almü Präzisions-Werkzeug GmbH (Almü), a Germany-based cutting tools and solutions provider within high-precision drilling, reaming, milling and tooling systems. The company will be reported in Sandvik Coromant, a division within Sandvik Manufacturing and Machining Solutions.  Almü was founded in 1978, has 44 employees, and is headquartered in Zell unter Aichelberg, Germany. In 2022, the company generated revenues of about approximately 6 MEUR. The impact on Sandvik’s EBITA margin and earnings per share will be limited.

poLight ASA: Mandatory notifications of trade - subscriptions by primary insiders in Rights Issue

Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding a partially underwritten rights issue of new shares (the "Offer Shares"), to raise gross proceeds of up to NOK 160 million (the "Rights Issue"), of which an underwriting consortium has agreed to underwrite subscription of new shares for gross proceeds of NOK 130 million. The following members of the Company's executive management has today subscribed for Offer Shares in the Rights Issue: - Øyvind Isaksen, Chief Executive Officer, has, through his wholly-owned company

Invitation to presentation of Tobii’s report for the first quarter 2024

Tobii will publish its interim report for the first quarter of 2024 on Thursday 16 May, at approximately 7.30 a.m. CEST. A webcast presentation will be held at 9:00 a.m. on the same day.CEO Anand Srivatsa and CFO Magdalena Rodell Andersson will present and comment on the report. The presentation will be held in English and will be followed by a Q&A session. Follow the webcasted presentation live at:https://ir.financialhearings.com/tobii-q1-report-2024 Please make sure you are connected to the webcast by logging in a few minutes before the presentation begins. It will be possible to

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 102 – 3 MAJ 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

BioStock: CombiGene’s pain programme takes important steps forward

CombiGene is moving towards the toxicological studies in the COZY01 pain project, which is being conducted in collaboration with the Danish biotech company Zyneyro.  – We will continue to work methodically to complete the preclinical studies needed in order to be able to start the preclinical toxicology programme, says CombiGene’s CEO Peter Ekolind.Read the full interview with Peter Ekolind at biostock.se: https://www.biostock.se/en/2024/05/combigenes-pain-programme-takes-important-steps-forward/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

BioStock: Prolight Diagnostics selects partner to conduct clinical validation studies

Prolight Diagnostics has appointed MDx CRO to perform clinical validation studies with the company's digital point-of-care analysis system, Psyros, for high sensitivity troponin testing. The clinical validation is planned to start in early 2025 and is expected to form the basis for IVDR approval and commerical launch.– With MDx, we have gained an extremely experienced and responsive partner with deep sector knowledge and high expertise, says CEO Ulf Bladin.Read the article at biostock.se: Prolight Diagnostics selects partner to conduct clinical validation studies - BioStock 

Decarbonising the Italian pulp & paper industry

AFRY is collaborating with Italian paper association, Assocarta, to develop a net-zero roadmap for the pulp and paper sector in Italy.AFRY has been selected by Assocarta to define a decarbonisation strategy for the pulp and paper sector that is in line with EU framework, country-specific conditions, and technological advancements. AFRY’s assessment will outline an overall decarbonisation roadmap for the sector, pinpointing the best available technologies, regulatory and infrastructural obstacles, and competitive levers. Additionally, AFRY will provide an analysis of the pulp & paper sector

Aonic AB (publ) publishes interim report for Q1 2024

Press releaseFRI, MAY 3, 2024, [09.00] CEST Aonic AB (publ) has today published its Q1 2024 report on the company's website https://aonic.co/. The report is available on the company's website as a PDF.  For further information, please contact: Paul Schempp, CEO +46 76 344 53 77 paul.schempp@aonic.co Fredrik Iversen, CFO +46 76 040 86 21 fredrik.iversen@aonic.co The information was submitted for publication, through the agency of the contact persons set out above, at [09.00] CEST on May 3, 2024. About Aonic AB (publ) Aonic is a video gaming group

Ericsson to utilize mandate to transfer shares

Ericsson’s (NASDAQ:ERIC) annual general meeting on April 3, 2024 authorized the company to, in conjunction with the delivery of vested shares under the long-term variable compensation program 2021 (“LTV 2021”), prior to the annual general meeting in 2025, retain and sell no more than 60% of the vested LTV 2021 shares of series B in the company in order to cover for the costs for withholding and paying tax and social security liabilities on behalf of the participants in relation to the performance share awards for remittance to revenue authorities. Ericsson has decided to utilize the

Correction: Invitation to presentation of first quarter results on 8 May 2024

Multiconsult (OSE: MULTI) Reference is made to the release issued 3 May 2024, 08:30 CET related to invitation of first quarter 2024 results: Heading referred to the year 2023, the correct year should be 2024.Corrected release follows:______ Invitation to presentation of first quarter results on 8 May 2024 Multiconsult (OSE: MULTI) first quarter 2024 results will be released on Wednesday 8 May at 07:00 CET. Multiconsult hereby invites you to the presentation of the results and participants are invited to attend. The Norwegian presentation will be held at Hotel Continental,

Insider information: The CEO of Enersense leaves his position

Enersense International PlcInsider information 3 May 2024 at 9.45 a.m.Enersense International Plc and the company's CEO Jussi Holopainen have agreed that Holopainen will leave his position on May 3, 2024. "Jussi Holopainen has been with Enersense almost from the company's inception, of which the last 11 years as the company's CEO. During Holopainen's time, the company has developed strongly, it has been listed on the Helsinki Stock Exchange, and the company's growth has been strong. On behalf of the entire company, I would like to express my great thanks to Jussi for his work and wish

Heliospectra (publ) Publish the Quarter Report for Jan-Mar 2024

(GOTHENBURG, Sweden, May 3, 2024, at 08:40 CEST)– Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Quarter Report for the period January to March 2024.Full report is enclosed to this press release and is also uploaded at https://heliospectra.com/investor-relations/financial-reports-documents/reports/. SUMMARY OF REPORT Sales and financial performance January – March 2024 · Order intake during the period amounted to SEK 26,828 (1,649) thousand. · Net sales during the period amounted to SEK

There are no items matching the current filter
There are no more items matching the current filter
Back to top